Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 167   

Articles published

GSK 1,534.50
price chart
Pre-Earnings GlaxoSmithKline plc. (GSK) Traders Have a Change of Heart
GlaxoSmithKline plc (ADR) (NYSE:GSK) is adding to its modest 9.1% year-to-date advance, up 0.7% at $46.63, following news the firm's malaria vaccine -- the world's first licensed human vaccine -- could be granted approval for use in Africa.
Credit Suisse Group AG Reaffirms "Underperform" Rating for ...  Dakota Financial News
GlaxoSmithKline plc Earns "A+" Credit Rating from Morningstar (GSK)  The Legacy
3 Stocks To Ride Out Mayhem In May: British American Tobacco plc ...
My pick of big pharma is GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). GSK's scale gives it the R&D-spending power to be a winner in prescription drugs, whilst its vaccines and over-the-counter businesses provide stable earnings.
GlaxoSmithKline plc Given Hold Rating at Deutsche Bank (GSK)  Dakota Financial News
GlaxoSmithKline plc Given "Hold" Rating at Deutsche Bank (GSK)  sleekmoney
The Bedrock Of Your 5-Share Income Portfolio: GlaxoSmithKline plc
If you're going to buy just a handful of shares in the pursuit of an income yield well above that of the market, then investing in large stable companies with defensive business models is a must.
GlaxoSmithKline plc Earns Underperform Rating from Credit Suisse Group AG ...
GlaxoSmithKline plc logo Credit Suisse Group AG reissued their underperform rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a research note released on Wednesday morning.
GlaxoSmithKline plc's "Underperform" Rating Reiterated at BNP ...  WKRB News
Deutsche Bank Reaffirms "Hold" Rating for GlaxoSmithKline plc (GSK)  Mideast Time
According To This Fund Manager, GlaxoSmithKline plc Is A Tremendous ...
GlaxoSmithKline's (LSE: GSK) shares are a tremendous opportunity for income investors, according to Adrian Frost, manager of the �7.3 billion Artemis Income fund.
GlaxoSmithKline plc 13.6% Potential upside - 'OVERWEIGHT' Rating reiterated
GlaxoSmithKline plc with EPIC LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'OVERWEIGHT' today by analysts at Barclays Capital.
GlaxoSmithKline plc (ADR) to Close Its Pittsburg Office As It Consolidates ...  Bidness ETC
GlaxoSmithKline plc Now Covered by Societe Generale (GSK)  Dakota Financial News
Why GlaxoSmithKline plc Beats AstraZeneca plc And Royal Dutch Shell Plc ...
Pharmaceuticals and Big Oil are great sectors for the kind of long-term investment that ISAs are perfect for. It's generally better to put the tax-wrapper of an ISA around funds that you plan to leave to grow the longest.
GlaxoSmithKline plc Assigned A+ Credit Rating by Morningstar (GSK)  sleekmoney
GlaxoSmithKline plc vs AstraZeneca plc: Which Pharmaceutical Major Should ...
Since the turn of the year, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has easily outperformed AstraZeneca (LSE: AZN) (NYSE: AZN.
JPMorgan Chase & Co. Reiterates Underweight Rating for GlaxoSmithKline ...  The Legacy
GlaxoSmithKline plc Receives "A+" Credit Rating from Morningstar (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) has been given an �A+� credit rating by Morningstar. The investment research firm's �A+� rating indicates that the company is a low default risk.
GlaxoSmithKline plc (GSK) - Investment Analysts' Weekly Ratings Changes  WKRB News
Deutsche Bank Reiterates "Hold" Rating for GlaxoSmithKline plc (GSK)  Mideast Time
GlaxoSmithKline plc (ADR) Considers Changes To Its US Sales Staff ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been undergoing a seemingly rough patch in its US operations over the past year. In an attempt to remedy the situation, the company plans to make changes to its compensation program for its sales staff in the US ...
Glaxo Plans Changes to Compensation Program for U.S. Sales Team  Bloomberg